Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind study of lidocaine pertubation for unexplained infertility
2016-001950-16Phase 2Completed
- Sponsor
- Isifer AB
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Isifera Plus in Unexplained infertility (2 arms), sponsored by Isifer AB. Primary endpoint: Pregnancy rate. Started Jan 2017; status: completed.
02
Drugs
Isifera Plus
03
Conditions
Unexplained infertility
Beyond the preview
Go deeper on 2016-001950-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001950-16.